Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies.
Norsworthy KJ, Cho E, Arora J, Kowalski J, Tsai HL, Warlick E, Showel M, Pratz KW, Sutherland LA, Gore SD, Ferguson A, Sakoian S, Greer J, Espinoza-Delgado I, Jones RJ, Matsui WH, Smith BD.
Norsworthy KJ, et al. Among authors: cho e.
Leuk Res. 2016 Oct;49:90-7. doi: 10.1016/j.leukres.2016.09.003. Epub 2016 Sep 3.
Leuk Res. 2016.
PMID: 27619199
Free PMC article.
Clinical Trial.